Improving Survival in Metastatic Colorectal Cancer Through Optimized Patient Selection

Abstract: The systemic treatment options for patients with metastatic colorectal cancer have recently expanded with the US Food and Drug Administration approval of fruquintinib being added to […]

Back to Archive